Disease activity, damage and survival in Mexican patients with acute severe systemic lupus erythematosus

Abstract

Systemic lupus erythematosus (SLE) is a clinical syndrome of varying severity. Although the survival and prognosis of SLE have steadily improved, there is a group of patients who present an acute fatal outcome despite aggressive therapy. We designed this study to evaluate the factors associated with mortality in patients with acute severe SLE. During 2004-06, 41 Mexican SLE patients that could not be managed in the out-patient clinic and with acute severe major organ system involvement [nephritis, severe thrombocytopenia (platelet count below 20 000 per microL) acute neuropsychiatric pulmonary, gastrointestinal or cardiac disease and generalized vasculitis] were studied. During the first admission, disease activity (SLE Disease Activity Index (SLEDAI), SLE Activity Measured), damage [SLE International Collaborating Clinics (SLICC)], and therapy were assessed. Survival using Kaplan-Meier curves, odd ratios with 95% confidence interval and logistic regression analysis were used to determine risk factors for mortality. Ninety percent were female with a mean age of 29 +/- 19 years and mean disease duration of 21 +/- 9 months. The principal causes of first admission were renal (27%), SNC (22%) and cardiopulmonary (15%). After a mean follow-up of 9.7 +/- 6 months, 16 (39%) patients died. Deceased patients had significantly higher SLEDAI (P = 0.004), and SLICC (P = 0.03) scores. The manifestations associated with mortality were renal disease activity (odds ratio, OR 4.6, confidence interval, CI 95% 1.0-20.6), infections (OR 3.2 CI 95% 2.0-5.3) and thrombocytopenia (OR 4.0, CI 95% 1.0-15.9). The survival at 9.7 months was 72, 62 and 50% in patients with an SLEDAI score of 3-10, 11-20 and > or =21, respectively. The SLEDAI score, the presence of damage and infection were associated with death in patients with acute severe SLE.

Juvenile onset systemic lupus erythematosus thyroid dysfunction: A subgroup with mild disease?

“…Interestingly, the lower frequency of at least one major organ involvement (renal, neurological and/or hematological) in patients with either thyroid dysfunction or thyroid autoantibodies supports the notion of a mild disease in this subgroup of patients. Actually, a higher frequency of fatal outcome is associated with severe acute involvement of these organs despite aggressive therapy [29].…”

The impact of glucocorticoids and anti-cd20 therapy on cervical human papillomavirus infection risk in women with systemic lupus erythematosus

“…Mexican patients with SLE have an elevated risk of major organ involvement (13). This type of patient usually requires immunosuppressive drugs and even biologic therapy, which may increase the risk of squamous intraepithelial lesions in patients with cervical HPV infection.…”

Characteristics of comorbidities and costs among patients who died from systemic lupus erythematosus in Taiwan

“…In the USA, the increase in the number and the cost of avoidable hospitalizations has been remarkable among SLE patients [2]. Regarding mortality, a Mexican report has revealed a correlation between active lupus nephritis (LN) and infections [3]. A nationwide claim-based study in the USA has found that African Americans have higher mortality due to SLE than Caucasians [4].…”